Medical Care

Global Still’s Disease Treatment Market Research Report 2025

The global market for Still’s Disease Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Still’s disease is a rare rheumatic condition. This condition is characterized by biological and clinical symptoms such as high spiking fever, joint swelling, muscle pain, sore throat, increased number of white cells (leukocytes, especially neutrophils), and biological hepatitis. Treatment for still’s disease can be classified into 2 categories, namely symptomatic treatments and effective therapies. Symptomatic treatments can be initiated immediately, even when the diagnosis has not been established whereas, effective therapies are designed to treat the condition more efficiently to eradicate the symptoms of the disease.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Still’s Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Still’s Disease Treatment.
The Still’s Disease Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Still’s Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Still’s Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AB2 Bio Ltd
Novartis AG
F. Hoffmann-La Roche Ltd
Swedish Orphan Biovitrum AB
Jubilant
Hikma Pharmaceuticals PLC
Teva Pharmaceutical Industries Ltd
Viatris
Horizon Therapeutics plc
Sun Pharmaceutical Industries Ltd
Zydus Cadila
Amneal Pharmaceuticals LLC
Dr Reddy's Laboratories Ltd
Fresenius Kabi AG
Segment by Type
Corticosteroids
Tocilizumab
Canakinumab
Anakinra
Others
Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Still’s Disease Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Still’s Disease Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Corticosteroids
1.2.3 Tocilizumab
1.2.4 Canakinumab
1.2.5 Anakinra
1.2.6 Others
1.3 Market by Application
1.3.1 Global Still’s Disease Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Still’s Disease Treatment Market Perspective (2020-2031)
2.2 Global Still’s Disease Treatment Growth Trends by Region
2.2.1 Global Still’s Disease Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Still’s Disease Treatment Historic Market Size by Region (2020-2025)
2.2.3 Still’s Disease Treatment Forecasted Market Size by Region (2026-2031)
2.3 Still’s Disease Treatment Market Dynamics
2.3.1 Still’s Disease Treatment Industry Trends
2.3.2 Still’s Disease Treatment Market Drivers
2.3.3 Still’s Disease Treatment Market Challenges
2.3.4 Still’s Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Still’s Disease Treatment Players by Revenue
3.1.1 Global Top Still’s Disease Treatment Players by Revenue (2020-2025)
3.1.2 Global Still’s Disease Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Still’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Still’s Disease Treatment Revenue
3.4 Global Still’s Disease Treatment Market Concentration Ratio
3.4.1 Global Still’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Still’s Disease Treatment Revenue in 2024
3.5 Global Key Players of Still’s Disease Treatment Head office and Area Served
3.6 Global Key Players of Still’s Disease Treatment, Product and Application
3.7 Global Key Players of Still’s Disease Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Still’s Disease Treatment Breakdown Data by Type
4.1 Global Still’s Disease Treatment Historic Market Size by Type (2020-2025)
4.2 Global Still’s Disease Treatment Forecasted Market Size by Type (2026-2031)
5 Still’s Disease Treatment Breakdown Data by Application
5.1 Global Still’s Disease Treatment Historic Market Size by Application (2020-2025)
5.2 Global Still’s Disease Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Still’s Disease Treatment Market Size (2020-2031)
6.2 North America Still’s Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Still’s Disease Treatment Market Size by Country (2020-2025)
6.4 North America Still’s Disease Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Still’s Disease Treatment Market Size (2020-2031)
7.2 Europe Still’s Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Still’s Disease Treatment Market Size by Country (2020-2025)
7.4 Europe Still’s Disease Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Still’s Disease Treatment Market Size (2020-2031)
8.2 Asia-Pacific Still’s Disease Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Still’s Disease Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Still’s Disease Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Still’s Disease Treatment Market Size (2020-2031)
9.2 Latin America Still’s Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Still’s Disease Treatment Market Size by Country (2020-2025)
9.4 Latin America Still’s Disease Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Still’s Disease Treatment Market Size (2020-2031)
10.2 Middle East & Africa Still’s Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Still’s Disease Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Still’s Disease Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AB2 Bio Ltd
11.1.1 AB2 Bio Ltd Company Details
11.1.2 AB2 Bio Ltd Business Overview
11.1.3 AB2 Bio Ltd Still’s Disease Treatment Introduction
11.1.4 AB2 Bio Ltd Revenue in Still’s Disease Treatment Business (2020-2025)
11.1.5 AB2 Bio Ltd Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Still’s Disease Treatment Introduction
11.2.4 Novartis AG Revenue in Still’s Disease Treatment Business (2020-2025)
11.2.5 Novartis AG Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Details
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Still’s Disease Treatment Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Still’s Disease Treatment Business (2020-2025)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 Swedish Orphan Biovitrum AB
11.4.1 Swedish Orphan Biovitrum AB Company Details
11.4.2 Swedish Orphan Biovitrum AB Business Overview
11.4.3 Swedish Orphan Biovitrum AB Still’s Disease Treatment Introduction
11.4.4 Swedish Orphan Biovitrum AB Revenue in Still’s Disease Treatment Business (2020-2025)
11.4.5 Swedish Orphan Biovitrum AB Recent Development
11.5 Jubilant
11.5.1 Jubilant Company Details
11.5.2 Jubilant Business Overview
11.5.3 Jubilant Still’s Disease Treatment Introduction
11.5.4 Jubilant Revenue in Still’s Disease Treatment Business (2020-2025)
11.5.5 Jubilant Recent Development
11.6 Hikma Pharmaceuticals PLC
11.6.1 Hikma Pharmaceuticals PLC Company Details
11.6.2 Hikma Pharmaceuticals PLC Business Overview
11.6.3 Hikma Pharmaceuticals PLC Still’s Disease Treatment Introduction
11.6.4 Hikma Pharmaceuticals PLC Revenue in Still’s Disease Treatment Business (2020-2025)
11.6.5 Hikma Pharmaceuticals PLC Recent Development
11.7 Teva Pharmaceutical Industries Ltd
11.7.1 Teva Pharmaceutical Industries Ltd Company Details
11.7.2 Teva Pharmaceutical Industries Ltd Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd Still’s Disease Treatment Introduction
11.7.4 Teva Pharmaceutical Industries Ltd Revenue in Still’s Disease Treatment Business (2020-2025)
11.7.5 Teva Pharmaceutical Industries Ltd Recent Development
11.8 Viatris
11.8.1 Viatris Company Details
11.8.2 Viatris Business Overview
11.8.3 Viatris Still’s Disease Treatment Introduction
11.8.4 Viatris Revenue in Still’s Disease Treatment Business (2020-2025)
11.8.5 Viatris Recent Development
11.9 Horizon Therapeutics plc
11.9.1 Horizon Therapeutics plc Company Details
11.9.2 Horizon Therapeutics plc Business Overview
11.9.3 Horizon Therapeutics plc Still’s Disease Treatment Introduction
11.9.4 Horizon Therapeutics plc Revenue in Still’s Disease Treatment Business (2020-2025)
11.9.5 Horizon Therapeutics plc Recent Development
11.10 Sun Pharmaceutical Industries Ltd
11.10.1 Sun Pharmaceutical Industries Ltd Company Details
11.10.2 Sun Pharmaceutical Industries Ltd Business Overview
11.10.3 Sun Pharmaceutical Industries Ltd Still’s Disease Treatment Introduction
11.10.4 Sun Pharmaceutical Industries Ltd Revenue in Still’s Disease Treatment Business (2020-2025)
11.10.5 Sun Pharmaceutical Industries Ltd Recent Development
11.11 Zydus Cadila
11.11.1 Zydus Cadila Company Details
11.11.2 Zydus Cadila Business Overview
11.11.3 Zydus Cadila Still’s Disease Treatment Introduction
11.11.4 Zydus Cadila Revenue in Still’s Disease Treatment Business (2020-2025)
11.11.5 Zydus Cadila Recent Development
11.12 Amneal Pharmaceuticals LLC
11.12.1 Amneal Pharmaceuticals LLC Company Details
11.12.2 Amneal Pharmaceuticals LLC Business Overview
11.12.3 Amneal Pharmaceuticals LLC Still’s Disease Treatment Introduction
11.12.4 Amneal Pharmaceuticals LLC Revenue in Still’s Disease Treatment Business (2020-2025)
11.12.5 Amneal Pharmaceuticals LLC Recent Development
11.13 Dr Reddy's Laboratories Ltd
11.13.1 Dr Reddy's Laboratories Ltd Company Details
11.13.2 Dr Reddy's Laboratories Ltd Business Overview
11.13.3 Dr Reddy's Laboratories Ltd Still’s Disease Treatment Introduction
11.13.4 Dr Reddy's Laboratories Ltd Revenue in Still’s Disease Treatment Business (2020-2025)
11.13.5 Dr Reddy's Laboratories Ltd Recent Development
11.14 Fresenius Kabi AG
11.14.1 Fresenius Kabi AG Company Details
11.14.2 Fresenius Kabi AG Business Overview
11.14.3 Fresenius Kabi AG Still’s Disease Treatment Introduction
11.14.4 Fresenius Kabi AG Revenue in Still’s Disease Treatment Business (2020-2025)
11.14.5 Fresenius Kabi AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Still’s Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Corticosteroids
Table 3. Key Players of Tocilizumab
Table 4. Key Players of Canakinumab
Table 5. Key Players of Anakinra
Table 6. Key Players of Others
Table 7. Global Still’s Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Still’s Disease Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Still’s Disease Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Still’s Disease Treatment Market Share by Region (2020-2025)
Table 11. Global Still’s Disease Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Still’s Disease Treatment Market Share by Region (2026-2031)
Table 13. Still’s Disease Treatment Market Trends
Table 14. Still’s Disease Treatment Market Drivers
Table 15. Still’s Disease Treatment Market Challenges
Table 16. Still’s Disease Treatment Market Restraints
Table 17. Global Still’s Disease Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Still’s Disease Treatment Market Share by Players (2020-2025)
Table 19. Global Top Still’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Still’s Disease Treatment as of 2024)
Table 20. Ranking of Global Top Still’s Disease Treatment Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Still’s Disease Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Still’s Disease Treatment, Headquarters and Area Served
Table 23. Global Key Players of Still’s Disease Treatment, Product and Application
Table 24. Global Key Players of Still’s Disease Treatment, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Still’s Disease Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Still’s Disease Treatment Revenue Market Share by Type (2020-2025)
Table 28. Global Still’s Disease Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Still’s Disease Treatment Revenue Market Share by Type (2026-2031)
Table 30. Global Still’s Disease Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Still’s Disease Treatment Revenue Market Share by Application (2020-2025)
Table 32. Global Still’s Disease Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Still’s Disease Treatment Revenue Market Share by Application (2026-2031)
Table 34. North America Still’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Still’s Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Still’s Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Still’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Still’s Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Still’s Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Still’s Disease Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Still’s Disease Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Still’s Disease Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Still’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Still’s Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Still’s Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Still’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Still’s Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Still’s Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 49. AB2 Bio Ltd Company Details
Table 50. AB2 Bio Ltd Business Overview
Table 51. AB2 Bio Ltd Still’s Disease Treatment Product
Table 52. AB2 Bio Ltd Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 53. AB2 Bio Ltd Recent Development
Table 54. Novartis AG Company Details
Table 55. Novartis AG Business Overview
Table 56. Novartis AG Still’s Disease Treatment Product
Table 57. Novartis AG Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 58. Novartis AG Recent Development
Table 59. F. Hoffmann-La Roche Ltd Company Details
Table 60. F. Hoffmann-La Roche Ltd Business Overview
Table 61. F. Hoffmann-La Roche Ltd Still’s Disease Treatment Product
Table 62. F. Hoffmann-La Roche Ltd Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 63. F. Hoffmann-La Roche Ltd Recent Development
Table 64. Swedish Orphan Biovitrum AB Company Details
Table 65. Swedish Orphan Biovitrum AB Business Overview
Table 66. Swedish Orphan Biovitrum AB Still’s Disease Treatment Product
Table 67. Swedish Orphan Biovitrum AB Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 68. Swedish Orphan Biovitrum AB Recent Development
Table 69. Jubilant Company Details
Table 70. Jubilant Business Overview
Table 71. Jubilant Still’s Disease Treatment Product
Table 72. Jubilant Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 73. Jubilant Recent Development
Table 74. Hikma Pharmaceuticals PLC Company Details
Table 75. Hikma Pharmaceuticals PLC Business Overview
Table 76. Hikma Pharmaceuticals PLC Still’s Disease Treatment Product
Table 77. Hikma Pharmaceuticals PLC Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 78. Hikma Pharmaceuticals PLC Recent Development
Table 79. Teva Pharmaceutical Industries Ltd Company Details
Table 80. Teva Pharmaceutical Industries Ltd Business Overview
Table 81. Teva Pharmaceutical Industries Ltd Still’s Disease Treatment Product
Table 82. Teva Pharmaceutical Industries Ltd Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 83. Teva Pharmaceutical Industries Ltd Recent Development
Table 84. Viatris Company Details
Table 85. Viatris Business Overview
Table 86. Viatris Still’s Disease Treatment Product
Table 87. Viatris Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 88. Viatris Recent Development
Table 89. Horizon Therapeutics plc Company Details
Table 90. Horizon Therapeutics plc Business Overview
Table 91. Horizon Therapeutics plc Still’s Disease Treatment Product
Table 92. Horizon Therapeutics plc Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 93. Horizon Therapeutics plc Recent Development
Table 94. Sun Pharmaceutical Industries Ltd Company Details
Table 95. Sun Pharmaceutical Industries Ltd Business Overview
Table 96. Sun Pharmaceutical Industries Ltd Still’s Disease Treatment Product
Table 97. Sun Pharmaceutical Industries Ltd Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 98. Sun Pharmaceutical Industries Ltd Recent Development
Table 99. Zydus Cadila Company Details
Table 100. Zydus Cadila Business Overview
Table 101. Zydus Cadila Still’s Disease Treatment Product
Table 102. Zydus Cadila Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 103. Zydus Cadila Recent Development
Table 104. Amneal Pharmaceuticals LLC Company Details
Table 105. Amneal Pharmaceuticals LLC Business Overview
Table 106. Amneal Pharmaceuticals LLC Still’s Disease Treatment Product
Table 107. Amneal Pharmaceuticals LLC Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 108. Amneal Pharmaceuticals LLC Recent Development
Table 109. Dr Reddy's Laboratories Ltd Company Details
Table 110. Dr Reddy's Laboratories Ltd Business Overview
Table 111. Dr Reddy's Laboratories Ltd Still’s Disease Treatment Product
Table 112. Dr Reddy's Laboratories Ltd Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 113. Dr Reddy's Laboratories Ltd Recent Development
Table 114. Fresenius Kabi AG Company Details
Table 115. Fresenius Kabi AG Business Overview
Table 116. Fresenius Kabi AG Still’s Disease Treatment Product
Table 117. Fresenius Kabi AG Revenue in Still’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 118. Fresenius Kabi AG Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 122. Authors List of This Report


List of Figures
Figure 1. Still’s Disease Treatment Picture
Figure 2. Global Still’s Disease Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Still’s Disease Treatment Market Share by Type: 2024 VS 2031
Figure 4. Corticosteroids Features
Figure 5. Tocilizumab Features
Figure 6. Canakinumab Features
Figure 7. Anakinra Features
Figure 8. Others Features
Figure 9. Global Still’s Disease Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Still’s Disease Treatment Market Share by Application: 2024 VS 2031
Figure 11. Retail Pharmacies Case Studies
Figure 12. Hospital Pharmacies Case Studies
Figure 13. Online Pharmacies Case Studies
Figure 14. Still’s Disease Treatment Report Years Considered
Figure 15. Global Still’s Disease Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Still’s Disease Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Still’s Disease Treatment Market Share by Region: 2024 VS 2031
Figure 18. Global Still’s Disease Treatment Market Share by Players in 2024
Figure 19. Global Top Still’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Still’s Disease Treatment as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Still’s Disease Treatment Revenue in 2024
Figure 21. North America Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Still’s Disease Treatment Market Share by Country (2020-2031)
Figure 23. United States Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Still’s Disease Treatment Market Share by Country (2020-2031)
Figure 27. Germany Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Still’s Disease Treatment Market Share by Region (2020-2031)
Figure 35. China Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Still’s Disease Treatment Market Share by Country (2020-2031)
Figure 43. Mexico Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Still’s Disease Treatment Market Share by Country (2020-2031)
Figure 47. Turkey Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Still’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. AB2 Bio Ltd Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 51. Novartis AG Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 52. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 53. Swedish Orphan Biovitrum AB Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 54. Jubilant Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 55. Hikma Pharmaceuticals PLC Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 56. Teva Pharmaceutical Industries Ltd Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 57. Viatris Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 58. Horizon Therapeutics plc Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 59. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 60. Zydus Cadila Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 61. Amneal Pharmaceuticals LLC Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 62. Dr Reddy's Laboratories Ltd Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 63. Fresenius Kabi AG Revenue Growth Rate in Still’s Disease Treatment Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies